Recombinant human interleukin 5 is a selective activator of human eosinophil function

Journal of Experimental Medicine

Volumn 167, Issue 1, 1988, Pages 219-224

  Lopez, Angel F ^a   Sanderson, Colin J ^b   Gamble, Jennifer R ^a   Campbell, Hugh D ^c   Young, Ian G ^c   Vadas, Mathew A ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5;

EOSINOPHILIA; GENETIC ENGINEERING; HUMAN; HUMAN CELL; NORMAL HUMAN; RESPIRATORY BURST;

EOSINOPHILS; HUMAN; INTERLEUKIN-5; INTERLEUKINS; NEUTROPHILS; RECOMBINANT PROTEINS; SUPEROXIDES; SUPPORT, NON-U.S. GOV'T;

EID: 0023879839     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.167.1.219     Document Type: Article

References (22)

1. Tai, P. C, and C. J. F. Spry. 1976. Studies on blood eosinophils. I. Patients with transient eosinophilia. Clin. Exp. Immunol. 24:415.
2. David, J. R., M. A. Vadas, A. E. Butterworth, P. A. de Brito, E. M. Carvalho, R. A. David, J. A. Bina, and Z. A. Andrade. 1980. Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N. Engl. J. Med. 303:1147.
3. Veith, M. C, A. E. Butterworth, and A. W. Boylston. 1983. The enhancement of eosinophil-mediated killing of schistosomula of Schistosoma mansoni by mononuclear cell products. In Immunobiology of the Eosinophil. T. Yoshida, and M. Torisu, editors. Elsevier Science Publishing Co. Inc., New York. 305-325.
4. Sanderson, C. J., D. j. Warren, and M. Strath. 1985. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin-3, and functional properties of eosinophils produced in cultures. J. Exp. Med. 162:60.
5. Lopez, A. F., C. G. Begley, D. J. Williamson, D. J. Warren, M. A. Vadas, and C. J. Sanderson. 1986. Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. J. Exp. Med. 163:1085.
6. Azuma, C, T. Tanabe, M. Konishi, T. Kinashi, T. Noma, F. Matsuda, Y. Yaoita, K. Takatsu, L. Hammarstrom, C. I. E. Smith, E. Severinson, and T. Honjo. 1986. Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. Nucleic Acids Res. 14:9149.
7. Campbell, H. D., W. Q. J. Tucker, Y. Hon, M. E. Martinson, G. Mayo, E. J. Clutterbuck, C. J. Sanderson, and I. G. Young. 1987. Molecular cloning and expression of the gene encoding human eosinophil differentiation factor (interleukin-5). Proc. Natl. Acad. Sci. USA. 84:6629.
8. Vadas, M. A., J. R. David, A. Butterworth, N. T. Pisani, and T. A. Siongok. 1979. A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. J. Immunol. 122:1228.
9. Vadas, M. A., N. A. Nicola, and D. Metcalf. 1983. Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. J Immunol. 130:795.
10. Metcalf, D., C. G. Begley, G. R.Johnson, N. A. Nicola, M. A. Vadas, A. F. Lopez, D. J. Williamson, G. G. Wong, S. C. Clark, and E. A. Wang. 1986. Biological properties in vitro of a recombinant human granulocyte-macrophage colony stimulating factor. Blood. 67:37.
11. Lopez, A. F., D. J. Williamson, J. R. Gamble, C. G. Begley, J. M. Harlan, S. J. Klebanoff, A. Waltersdorph, G. Wong, S. C. Clark, and M. A. Vadas. 1986. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin. Invest. 78:1220.
12. Guli, I., and R. Snyderman. 1984. Rapid changes in light scattering from human polymorphonuclear leukocytes exposed to chemoattractants. Discrete responses correlated with chemotactic and secretory functions. J. Clin. Invest. 73:1408.
13. Howard, T. O., and C. O. Oresajo. 1985. The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils. J. Cell. Biol. 101:1078.
14. Bass, D. A., W. H. Grover.J. C. Lewis, P. Szejda, L. R. de Chatelet, and C. E. McCall. 1980. Comparison of human eosinophils from normals and patients with eosinophilia. J. Clin. Invest. 66:1265.
15. Tauber, A. I., A. J. Goetzl, and B. M. Babior. 1979. Unique characteristics of superoxide production by human eosinophils in eosinophilic states. Inflammation. 3:261.
16. Sanderson, C. J., A. F. Lopez, and M. M. Bunn Moreno. 1977. Eosinophils and not lymphoid K cells kill Trypanosoma cruzi epimastigotes. Nature (Lond.). 268:340.
17. Spry, C. J., A. P. Weetman, I. Olsson, P-C. Tai, and E. G. Olsen. 1985. The pathogenesis of eosinophilic endomyocardial disease in patients with carcinomas of the lung. Heart Vessels. 1:162.
18. Kodama, T., K. Takada, T. Kameya, Y. Shimosato, R. Tsuchiya, and T. Okabe. 1984. Large cell carcinoma of the lung associated with marked eosinophilia. Cancer (Phila.). 54:2313.
19. Catovsky, D., C. Bernasconi, P.J. Verdonck, A. Postma, J. Hows, van den Berg-van der Does, J. K. H. Rees, G. Castelli, E. Morra, and D. A. G. Galton. 1980. The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients. Br. J. Haematol. 45:523.
20. Silberstein, D. S., W. F. Owen, J. C. Gasson, J. F. Dipersio, D. W. Golde.J. C. Bina, R. Soberman, K. F. Austen, and J. R. David. 1986. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J. Immunol. 137:3290.
21. Lopez, A. F., L-B. To, Y-C. Yang, J. R. Gamble, M. F. Shannon, G. F. Burns, P. G. Dyson, C. A. Juttner, S. Clark, and M. A. Vadas. 1987. Stimulation of proliferation, differentiation and function of human cells by primate IL-3. Proc. Natl. Acad. Sci. USA. 84:2761.
22. Silberstein, D. S., and J. R. David. 1986. Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proc. Natl. Acad. Sci. USA. 83:1055.